| 1 | A1 | Human | F | 21 y | Breast (Bst) | Normal | Benign non-neoplastic | | |
| 1 | A2 | Human | F | 15 y | Breast (Bst) | Normal | Benign non-neoplastic | | |
| 1 | A3 | Human | F | 21 y | Breast (Bst) | Normal | Benign non-neoplastic | | |
| 1 | A4 | Human | F | 18 y | Breast (Bst) | Normal | Benign non-neoplastic | | |
| 1 | A5 | Human | F | 26 y | Breast, Fibrofatty tissue (Bst) | Normal | Benign non-neoplastic | | |
| 1 | A6 | Human | F | 40 y | Breast, Lobule (Bst) | Hyperplasia | Diseased | | |
| 1 | A7 | Human | F | 61 y | Breast, Lobule (Bst) | Hyperplasia | Diseased | | |
| 1 | A8 | Human | F | 42 y | Breast, Lobule (Bst) | Hyperplasia | Diseased | | |
| 1 | B1 | Human | F | 46 y | Breast, Lobule (Bst) | Hyperplasia | Diseased | | |
| 1 | B2 | Human | F | 22 y | Breast (Bst) | Hyperplasia, Cystic | Diseased | | |
| 1 | B3 | Human | F | 35 y | Breast, Lobule (Bst) | Hyperplasia | Diseased | | |
| 1 | B4 | Human | F | 40 y | Breast, Lobule (Bst) | Hyperplasia | Diseased | | |
| 1 | B5 | Human | F | 72 y | Breast, Lobule (Bst) | Hyperplasia | Diseased | | |
| 1 | B6 | Human | F | 48 y | Breast, Lobule (Bst) | Hyperplasia, Mild atypical | Diseased | | |
| 1 | B7 | Human | F | 53 y | Breast, Lobule (Bst) | Hyperplasia, Atypical | Diseased | | |
| 1 | B8 | Human | F | 40 y | Breast (Bst) | Lobular carcinoma in situ | Malignant | TisN0M0 | |
| 1 | C1 | Human | F | 62 y | Breast (Bst) | Lobular carcinoma in situ | Malignant | TisN0M0 | |
| 1 | C2 | Human | F | 49 y | Breast (Bst) | Lobular carcinoma in situ | Malignant | TisN0M0 | |
| 1 | C3 | Human | F | 48 y | Breast (Bst) | Lobular carcinoma in situ | Malignant | TisN0M0 | |
| 1 | C4 | Human | F | 49 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| 1 | C5 | Human | F | 46 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| 1 | C6 | Human | F | 41 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| 1 | C7 | Human | F | 40 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| 1 | C8 | Human | F | 30 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| 1 | D1 | Human | F | 43 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| 1 | D2 | Human | F | 49 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| 1 | D3 | Human | F | 39 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| 1 | D4 | Human | F | 67 y | Breast (Bst) | Intraductal carcinoma, Comedo-type with early infiltration | Malignant | T2N0M0 | |
| 1 | D5 | Human | F | 58 y | Breast (Bst) | Intraductal carcinoma, Comedo-type with early infiltration | Malignant | T1N0M0 | |
| 1 | D6 | Human | F | 38 y | Breast (Bst) | Intraductal carcinoma, Comedo-type with early infiltration | Malignant | T2N0M0 | |
| 1 | D7 | Human | F | 31 y | Breast (Bst) | Intraductal carcinoma, Comedo-type with early infiltration | Malignant | T2N0M0 | |
| 1 | D8 | Human | F | 48 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T3N2M1 | 1 |
| 1 | E1 | Human | F | 34 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 1 |
| 1 | E2 | Human | F | 39 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N1M0 | 2 |
| 1 | E3 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T3N0M0 | 2 |
| 1 | E4 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T1N0M0 | 2 |
| 1 | E5 | Human | F | 42 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T4N1M0 | 2 |
| 1 | E6 | Human | F | 65 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N2M0 | |
| 1 | E7 | Human | F | 53 y | Breast, Blood vessel (Bst) | Ductal carcinoma, infiltrating with carcinomatous embolus | Malignant | T4N0M0 | 2 |
| 1 | E8 | Human | F | 32 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T1N0M0 | 3 |
| 1 | F1 | Human | F | 42 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T1N0M0 | |
| 1 | F2 | Human | F | 38 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N0M0 | |
| 1 | F3 | Human | F | 35 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | TxN0M0 | |
| 1 | F4 | Human | F | 52 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N0M0 | |
| 1 | F5 | Human | F | 52 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T1N0M0 | |
| 1 | F6 | Human | F | 52 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | TxN0M0 | |
| 1 | F7 | Human | F | 51 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N0M0 | |
| 1 | F8 | Human | F | 47 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T1N0M0 | |
